Exploring genetic factors in autism and related disorders
Official title: Study of the Genetic Factors Involved in Autism and Related Disorders
Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT04727489 · Data updated 2026-11-12
This study is trying to find out how certain genes might be linked to autism and related disorders by looking closely at genetic variations in large groups of people.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 24 Months to 70 Years |
| Sex | All |
| Enrollment | 3800 (estimated) |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France Government |
| Locations | 6 sites (Grenoble, Grenoble and 5 other locations) |
| Status | Recruiting |
| Started | March 30, 2021 |
| Main results expected | March 2036 |
| Study ends | March 2036 |
| Registry record updated | December 23, 2025 |
| Trial ID | NCT04727489 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with Autism Spectrum Disorder aged 24 months or older, as well as control participants without ASD.
✕Probably not a fit
Patients who do not meet the diagnostic criteria for Autism Spectrum Disorder or are unable to provide informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to investigate the genetic variations in synaptic pathways associated with Autism Spectrum Disorder (ASD) using large cohorts of patients. Researchers will perform targeted sequencing of specific synaptic genes, focusing on both coding and regulatory regions that have not been previously tested. The study will also analyze genomic data from various sequencing methods to establish genotype/phenotype correlations and identify neuronal phenotypes linked to genetic mutations. This comprehensive approach seeks to enhance understanding of the genetic underpinnings of ASD for future therapeutic development.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies for Autism Spectrum Disorder based on genetic insights.
How similar studies have gone: Previous studies have shown promise in identifying genetic factors related to Autism Spectrum Disorder, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria--------------------------------------------------------------------------------------------------- Probands with Autism Spectrum Disorder * Meet the diagnostic criteria for ASD of the DSM-5 \[American Psychiatric Association, 2013\] based on a consensus between the clinical expertise of expert clinicians, the scores of the Autism Diagnostic Interview-Revised (ADI-R) (Rutter et al, 2003) and those of the Autism Diagnosis Observation Schedule (ADOS-2) (Lord et al, 2012) * Be at least 24 months (no upper age limit) * Somatic and Intellectual state compatible with a blood test * Affiliation to the social insurance * Signature of informed consent by the applicant or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship Controls without ASD * At least 24 months old * Somatic and Intellectual state compatible with a blood test * Affiliation to the social insurance * Signature of informed consent by the subject or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship Relatives of the probands with ASD or of controls without ASD * At least 24 months old * Somatic and Intellectual state compatible with a blood test * Affiliation to the social insurance * Signature of informed consent by the subject or by holders of parental authority if the subject is a minor or by the guardian if the subject is under guardianship Exclusion Criteria -------------------------------------------------------------------------------------------------- Probands with Autism Spectrum Disorder * Severe Intelectual Deficiency (IQ,35 or developmental age \<18 months) ●. Personal psychiatric history (schizophrenia, bipolar disorder, substance use disorder (except tobacco), recurrent depression disorder, severe instable anxiety disorder) * Personal neurologic history (epilepsy, or severe neurological disease) Relatives of the probands with ASD, of the controls or the controls: ● Medical condition (psychiatric or somatic) not compatible with the inclusion
Where it's running
-
CIC, CHU Bordeaux
Bordeaux, France Recruiting -
CRA, Hopital Charles Perrens, Bordeaux
Bordeaux, France Recruiting -
Centre de rehabilitation psychosociale, Hopital Saint Egreve
Grenoble, Grenoble, France Not yet recruiting -
CIC, H. Mondor, Creteil
Créteil, France Not yet recruiting -
Albert Chenevier Hospital
Créteil, Île-de-France Region, France Not yet recruiting -
Robert Debré Hospital
Paris, Île-de-France Region, France Not yet recruiting
Study contacts
- Principal investigator: Richard Delorme, M.D, Ph.D — Institut National de la Santé Et de la Recherche Médicale, France
- Study coordinator: Richard Delorme, M.D, Ph.D
- Email: richard.delorme@aphp.fr
- Phone: +33662725334
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensory Integration and Deep Pressure Therapy for Motor Coordination in Children with ASD
This study tests whether combining Sensory Integration Therapy with Deep Pressure Therapy can improve motor coordination and reduce repetitive behaviors in children aged 4–10 with autism.
-
Pupillometer screen to help identify autism in kids aged 2–4 during routine visits
A handheld pupillometer test is being tried to see if it can help identify autism in young children during regular pediatric visits.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.
-
Structured Sensory-Based Occupational Therapy for Children with Autism
This study tests a 12-week, 40-minute sensory-based occupational therapy program twice a week to see if it improves daily skills, sensory processing, movement, and eating in children aged 3-9 with autism.
-
Exergaming and Aerobic Exercise for Kids with Autism
This study tests whether adding exergames or aerobic exercise to a standard program helps improve sleep, movement skills, thinking skills, and brain activity in children with autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.